Bioequivalence and Bioavailability Forum

Main page Policy Latest Posts Abbreviations

Truncation of ER formulation [Design Issues]

posted by Compliance – India, 2013-01-16 10:48 (4912 d 10:55 ago) – Posting: # 9861
Views: 3,710

Dear All,

Is it possible to have truncation (due to long half life) study design for ER formulation? If you have any information please share.

Regards,

compliance

Complete thread:

Truncation of ER formulationCompliance 2013-01-16 09:48
- Truncation of ER formulation: problematic Helmut 2013-01-16 14:20
  - Truncation of ER formulation: problematic jag009 2013-01-16 15:59

Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
216 visitors (0 registered, 216 guests [including 17 identified bots]).
Forum time: 22:44 CEST (Europe/Vienna)

Most scientists today are devoid of ideas, full of fear, intent on
producing some paltry result so that they can add to the flood
of inane papers that now constitutes “scientific progress”
in many areas. Paul Feyerabend

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC

Ing. Helmut Schütz